Medicines and Medical Devices Safety Independent Review

(asked on 9th July 2020) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to work with (a) Epilepsy Action and (b) other (i) patient groups and (ii) charities to ensure that the recommendations of the Independent Medicines and Medical Devices Safety Review are implemented.


Answered by
Nadine Dorries Portrait
Nadine Dorries
This question was answered on 22nd July 2020

The Medicines and Healthcare products Regulatory Agency (MHRA) is working with the Valproate Stakeholder Network (which is composed of over 40 representatives including Epilepsy Action, other charities and patient groups) to improve compliance with the valproate Pregnancy Prevention Programme which aims to rapidly reduce and eventually eliminate pregnancies exposed to valproate. The MHRA is also working on developing a valproate registry, the main aims of which would be to monitor the use of valproate in girls and women in the United Kingdom and compliance with the current regulatory position, and to identify and monitor any children born to women on valproate.

Baroness Cumberlege was asked to review what happened in the three cases and we will consider her recommendations carefully.

Reticulating Splines